Calidi Biotherapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.45 | -$1.45 | -$1.45 |
| Q2 2024 | 1 | -$0.86 | -$0.86 | -$0.86 |
| Q3 2024 | 2 | -$0.44 | -$0.32 | -$0.38 |
Calidi Biotherapeutics, Inc. Earnings Date And Information
Calidi Biotherapeutics, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-1.4 earnings per share for the quarter, topping analysts' consensus estimates of $-1.43 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Calidi Biotherapeutics, Inc. has generated $-2 earnings per share over the last year ($-17.3 diluted earnings per share) and currently has a price-to-earnings ratio of -0.85. Calidi Biotherapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Calidi Biotherapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.65 | $0 | $0 | ||
| 08/13/2024 | Q2 2024 | -$1.43 | -$1.40 | 0.03 | $0 | $0 |
| 03/30/2024 | Q1 2024 | -$2.03 | $0 | |||
| 12/30/2023 | Q4 2023 | -$1.00 | $0 | |||
| 09/29/2023 | Q3 2023 | -$1.41 | $0 | |||
| 06/28/2023 | Q2 2023 | -$4.32 | $0 | |||
| 03/30/2023 | Q1 2023 | -$2.25 | $0 | |||
| 12/30/2022 | Q4 2022 | -$2.62 | $0 | |||
| 09/28/2022 | Q3 2022 | $0.19 | $0 | |||
| 06/28/2022 | Q2 2022 | $1.45 | $0 | |||
| 03/29/2022 | Q1 2022 | $0.51 | $0 | |||
| 12/29/2021 | Q4 2021 | $1.49 | $0 | |||
| 09/28/2021 | Q3 2021 | -$0.29 | $0 |
Calidi Biotherapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Calidi Biotherapeutics, Inc.'s earnings date?
Calidi Biotherapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
Did Calidi Biotherapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Calidi Biotherapeutics, Inc. (:CLDI) reported $-1.4 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.43 by $0.03.
-
How can I listen to Calidi Biotherapeutics, Inc.'s earnings conference call?
The conference call for Calidi Biotherapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Calidi Biotherapeutics, Inc.'s conference call transcript?
The conference call transcript for Calidi Biotherapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Calidi Biotherapeutics, Inc. generate each year?
Calidi Biotherapeutics, Inc. (:CLDI) has a recorded net income of $0. Calidi Biotherapeutics, Inc. has generated $-1.73 earnings per share over the last four quarters.
-
What is Calidi Biotherapeutics, Inc.'s price-to-earnings ratio?
Calidi Biotherapeutics, Inc. (:CLDI) has a price-to-earnings ratio of -0.85 and price/earnings-to-growth ratio is -0.11.
